NASDAQ:PLSE

Pulse Biosciences News Headlines

$22.86
+1.85 (+8.81 %)
(As of 09/17/2021 12:00 AM ET)
Add
Compare
Today's Range
$20.72
$22.92
50-Day Range
$17.84
$26.63
52-Week Range
$10.56
$45.82
Volume145,600 shs
Average Volume112,038 shs
Market Capitalization$676.79 million
P/E RatioN/A
Dividend YieldN/A
Beta1.63

Media Mentions By Week

Pulse Biosciences Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PLSE
News Sentiment

0.00

0.32

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PLSE Articles
This Week

0

1

PLSE Articles
Average Week

Get Pulse Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter.

Pulse Biosciences (NASDAQ PLSE) News Headlines Today

SourceHeadline
Pulse Biosciences (NASDAQ:PLSE) Shares Gap Down to $22.19Pulse Biosciences (NASDAQ:PLSE) Shares Gap Down to $22.19
americanbankingnews.com - September 10 at 12:16 PM
Pulse Biosciences (NASDAQ:PLSE)  Shares Down 5.1% Pulse Biosciences (NASDAQ:PLSE) Shares Down 5.1%
americanbankingnews.com - September 9 at 3:44 PM
 Analysts Expect Pulse Biosciences, Inc. (NASDAQ:PLSE) to Announce -$0.54 Earnings Per Share Analysts Expect Pulse Biosciences, Inc. (NASDAQ:PLSE) to Announce -$0.54 Earnings Per Share
americanbankingnews.com - September 9 at 1:12 AM
Is Pulse Biosciences (NASDAQ:PLSE) Weighed On By Its Debt Load?Is Pulse Biosciences (NASDAQ:PLSE) Weighed On By Its Debt Load?
finance.yahoo.com - September 3 at 10:41 PM
Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 6.1%Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 6.1%
americanbankingnews.com - September 3 at 12:34 PM
Pulse Biosciences (NASDAQ:PLSE) Shares Gap Down to $26.63Pulse Biosciences (NASDAQ:PLSE) Shares Gap Down to $26.63
americanbankingnews.com - August 31 at 12:36 PM
Pulse Biosciences (NASDAQ:PLSE) Trading 10.4% Higher Pulse Biosciences (NASDAQ:PLSE) Trading 10.4% Higher
americanbankingnews.com - August 30 at 1:20 PM
Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up to $23.40Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up to $23.40
americanbankingnews.com - August 26 at 11:54 AM
Pulse Biosciences Announces Appointment of Mitchell E. Levinson as Chief Strategy OfficerPulse Biosciences Announces Appointment of Mitchell E. Levinson as Chief Strategy Officer
finance.yahoo.com - August 19 at 9:19 PM
Pulse Biosciences Reports Second Quarter 2021 Financial ResultsPulse Biosciences Reports Second Quarter 2021 Financial Results
finance.yahoo.com - August 9 at 5:52 PM
Pulse Biosciences Inc hosts conference call for investorsPulse Biosciences Inc hosts conference call for investors
markets.businessinsider.com - July 29 at 11:38 PM
Pulse Biosciences Schedules Second Quarter 2021 Financial Results Conference Call for August 9, 2021Pulse Biosciences Schedules Second Quarter 2021 Financial Results Conference Call for August 9, 2021
finance.yahoo.com - July 26 at 7:06 PM
Robert Duggan Is The Independent Chairman of the Board of Pulse Biosciences, Inc. (NASDAQ:PLSE) And They Just Picked Up 25% More SharesRobert Duggan Is The Independent Chairman of the Board of Pulse Biosciences, Inc. (NASDAQ:PLSE) And They Just Picked Up 25% More Shares
finance.yahoo.com - July 6 at 8:12 AM
Pulse Biosciences Shares Rise Following Private Placement NewsPulse Biosciences Shares Rise Following Private Placement News
marketwatch.com - July 1 at 3:29 PM
Pulse Biosciences Stock Is Trading Higher After Companys Chairman Agrees To Buy Shares Worth $50MPulse Biosciences Stock Is Trading Higher After Company's Chairman Agrees To Buy Shares Worth $50M
markets.businessinsider.com - July 1 at 3:29 PM
Pulse Biosciences Announces $50 Million Private PlacementPulse Biosciences Announces $50 Million Private Placement
finance.yahoo.com - July 1 at 10:28 AM
Want to Buy Pulse Biosciences (NASDAQ: PLSE) Stock? See This First.Want to Buy Pulse Biosciences (NASDAQ: PLSE) Stock? See This First.
finance.yahoo.com - June 30 at 6:10 PM
Pulse Biosciences Announces First CellFX® Procedure Performed in CanadaPulse Biosciences Announces First CellFX® Procedure Performed in Canada
finance.yahoo.com - June 30 at 1:10 PM
Moving Average Crossover Alert: Pulse Biosciences (PLSE)Moving Average Crossover Alert: Pulse Biosciences (PLSE)
finance.yahoo.com - June 11 at 7:19 AM
Pulse Biosciences Announces Health Canada Approval for CellFX ® SystemPulse Biosciences Announces Health Canada Approval for CellFX ® System
businesswire.com - June 9 at 5:35 PM
Pulse Biosciences Announces Health Canada Approval for CellFX® SystemPulse Biosciences Announces Health Canada Approval for CellFX® System
au.finance.yahoo.com - June 9 at 12:34 PM
Pulse Biosciences to Participate in the Jefferies Healthcare ConferencePulse Biosciences to Participate in the Jefferies Healthcare Conference
finance.yahoo.com - May 24 at 1:07 PM
Pulse Biosciences shares are trading higher. Not seeing company-specific news since Co.s Monday earnings report.Pulse Biosciences shares are trading higher. Not seeing company-specific news since Co.'s Monday earnings report.
benzinga.com - May 14 at 7:29 AM
Pulse Biosciences® Presents Clinical Study Results of Nano-Pulse Stimulation™ Technology to Clear Benign Lesions at the American Society for Laser Medicine and Surgery (ASLMS) 2021 Virtual Annual ConferencePulse Biosciences® Presents Clinical Study Results of Nano-Pulse Stimulation™ Technology to Clear Benign Lesions at the American Society for Laser Medicine and Surgery (ASLMS) 2021 Virtual Annual Conference
finance.yahoo.com - May 13 at 12:44 PM
What You Need To Know About Pulse Biosciences, Inc.s (NASDAQ:PLSE) Investor CompositionWhat You Need To Know About Pulse Biosciences, Inc.'s (NASDAQ:PLSE) Investor Composition
finance.yahoo.com - May 11 at 3:33 PM
Pulse Biosciences Reports First Quarter 2021 Financial ResultsPulse Biosciences Reports First Quarter 2021 Financial Results
finance.yahoo.com - May 10 at 7:48 PM
Pulse Biosciences Schedules First Quarter 2021 Financial Results Conference Call for May 10, 2021Pulse Biosciences Schedules First Quarter 2021 Financial Results Conference Call for May 10, 2021
finance.yahoo.com - April 26 at 5:40 PM
Pulse Biosciences to Present Consumer Research on Patient Perceptions of Benign Lesion Clearance at American Academy of Dermatology VMX Meeting 2021Pulse Biosciences to Present Consumer Research on Patient Perceptions of Benign Lesion Clearance at American Academy of Dermatology VMX Meeting 2021
finance.yahoo.com - April 22 at 8:44 AM
Did Pulse Biosciences, Inc. (NASDAQ:PLSE) Insiders Buy Up More Shares?Did Pulse Biosciences, Inc. (NASDAQ:PLSE) Insiders Buy Up More Shares?
finance.yahoo.com - March 12 at 6:57 PM
Pulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q4 2020 Results - Earnings Call TranscriptPulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - February 24 at 2:26 PM
Pulse Biosciences Reports Fourth Quarter and Full Year 2020 Financial ResultsPulse Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results
finance.yahoo.com - February 22 at 7:12 PM
Pulse Biosciences Announces First CellFX Procedures Performed in Europe as Part of Global Controlled LaunchPulse Biosciences Announces First CellFX Procedures Performed in Europe as Part of Global Controlled Launch
finance.yahoo.com - February 19 at 8:03 AM
Pulse Biosciences Announces Start of Controlled Launch of the CellFX System®Pulse Biosciences Announces Start of Controlled Launch of the CellFX System®
finance.yahoo.com - February 16 at 12:02 PM
Pulse Biosciences Schedules Fourth Quarter and Full Year 2020 Financial Results Conference Call for February 22, 2021Pulse Biosciences Schedules Fourth Quarter and Full Year 2020 Financial Results Conference Call for February 22, 2021
finance.yahoo.com - February 12 at 12:35 PM
Pulse Biosciences, Inc. Announces At-The-Market Equity Offering ProgramPulse Biosciences, Inc. Announces At-The-Market Equity Offering Program
finance.yahoo.com - February 4 at 1:23 PM
Pulse Biosciences Announces FDA Clearance for the CellFX® SystemPulse Biosciences Announces FDA Clearance for the CellFX® System
finance.yahoo.com - February 3 at 9:40 AM
Pulse Biosciences, Inc.: Pulse Biosciences Announces CE Mark Approval for CellFX SystemPulse Biosciences, Inc.: Pulse Biosciences Announces CE Mark Approval for CellFX System
finanznachrichten.de - January 26 at 10:28 PM
Pulse Biosciences CellFX System U.S. application moves forward for general dermatology indicationPulse Biosciences' CellFX System U.S. application moves forward for general dermatology indication
seekingalpha.com - January 14 at 7:04 PM
Pulse Biosciences Updates on CellFX System Regulatory and Clinical Study ProgressPulse Biosciences Updates on CellFX System Regulatory and Clinical Study Progress
finance.yahoo.com - January 12 at 8:53 AM
Heres Why Were Watching Pulse Biosciences (NASDAQ:PLSE) Cash Burn SituationHere's Why We're Watching Pulse Biosciences' (NASDAQ:PLSE) Cash Burn Situation
finance.yahoo.com - January 11 at 5:52 PM
Pulse Biosciences, Inc. Announces Redemption of WarrantsPulse Biosciences, Inc. Announces Redemption of Warrants
finance.yahoo.com - January 5 at 11:42 AM
News for Pulse Biosciences IncNews for Pulse Biosciences Inc
markets.businessinsider.com - December 5 at 6:05 PM
Pulse Biosciences to Participate in Upcoming Investor ConferencesPulse Biosciences to Participate in Upcoming Investor Conferences
finance.yahoo.com - November 11 at 5:44 PM
What Kind Of Investors Own Most Of Pulse Biosciences, Inc. (NASDAQ:PLSE)?What Kind Of Investors Own Most Of Pulse Biosciences, Inc. (NASDAQ:PLSE)?
finance.yahoo.com - November 11 at 12:44 PM
Pulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q3 2020 Results - Earnings Call TranscriptPulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 10 at 1:47 AM
Pulse Biosciences Reports Third Quarter 2020 Financial ResultsPulse Biosciences Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 9 at 8:46 PM
Pulse Biosciences, Inc. (PLSE) Q3 2020 Earnings Call TranscriptPulse Biosciences, Inc. (PLSE) Q3 2020 Earnings Call Transcript
finance.yahoo.com - November 9 at 8:46 PM
Pulse Biosciences Schedules Third Quarter 2020 Financial Results Conference Call for November 9, 2020Pulse Biosciences Schedules Third Quarter 2020 Financial Results Conference Call for November 9, 2020
finance.yahoo.com - October 28 at 6:44 PM
Pulse Biosciences Announces Presentation of Clinical Results Using Nano-Pulse Stimulation Technology for the Clearance of Skin Lesions at the American Society for Dermatologic Surgery (ASDS) Virtual Annual MeetingPulse Biosciences Announces Presentation of Clinical Results Using Nano-Pulse Stimulation Technology for the Clearance of Skin Lesions at the American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting
finance.yahoo.com - October 8 at 9:30 AM
Stock Alert: Pulse Biosciences Jumps 23%Stock Alert: Pulse Biosciences Jumps 23%
nasdaq.com - October 5 at 12:31 PM
Get Pulse Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 9/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.